Transplantation of neural stem cells (NSCs) is a promising therapeutic approach for Huntington's disease (HD). HD is characterized by a progressive loss of medium-sized spiny neurons (MSNs) in the striatum. DARPP-32 (dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa) is expressed in 98% of these MSNs. To establish an effective cell therapy for HD, the differentiation of human NSCs into MSNs is essential. Enhancing differentiation of NSCs is therefore an important aspect to optimize transplant efficacy. A comparison of 5 differentiation protocols indicated that the Hedgehog agonist purmorphamine (1 μM) most significantly increased the neuronal differentiation of a human striatal NSC line (STROC05). This 3-fold increase in neurons was associated with a dramatic reduction in proliferation as well as a decrease in astrocytic differentiation. A synergistic effect between purmorphamine and cell density even further increased neuronal differentiation from 20% to 30% within 7 days. Upon long-term differentiation (21 days), this combined differentiation protocol tripled the number of DARPP-32 cells (7%) and almost doubled the proportion of calbindin cells. However, there was no effect on calretinin cells. Differential expression of positional specification markers (DLX2, MASH1, MEIS2, GSH2, and NKX2.1) further confirmed the striatal identity of these differentiated cells. Purmorphamine resulted in a significant upregulation of the Hedgehog (Hh) signaling pathway (GLI1 expression). Cyclopamine, an Hh inhibitor, blocked this effect, indicating that purmorphamine specifically acts through this pathway to increase neuronal differentiation. These results demonstrate that small synthetic molecules can play a pivotal role in directing the differentiation of NSCs to optimize their therapeutic potential in HD.
Get full access to this article
View all access options for this article.
References
1.
ModoM. 2008. Brain repair how stem cells are changing neurology. Bull Soc Sci Med Grand Duche Luxemb, 2:217–257.
2.
FrickerRA, TorresEM, HumeSP, MyersR, Opacka-JuffreyJ, AshworthS, BrooksDJ, DunnettSB. 1997. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. II. Correlation between positron emission tomography and reaching behaviour. Neuroscience, 79:711–21.
3.
FrickerRA, TorresEM, DunnettSB. 1997. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. I. Morphological characteristics. Neuroscience, 79:695–710.
4.
Bachoud-LeviA, BourdetC, BrugieresP, NguyenJP, GrandmouginT, HaddadB, JenyR, BartolomeoP, BoisseMF, BarbaGD, DegosJD, ErgisAM, LefaucheurJP, LisovoskiF, PailhousE, RemyP, PalfiS, DeferGL, CesaroP, HantrayeP, PeschanskiM. 2000. Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp Neurol, 161:194–202.
5.
KopyovOV, JacquesS, LiebermanA, DumaCM, EagleKS. 1998. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp Neurol, 149:97–108.
6.
RosserAE, BarkerRA, HarrowerT, WattsC, FarringtonM, HoAK, BurnsteinRM, MenonDK, GillardJH, PickardJ, DunnettSB. 2002. Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. J Neurol Neurosurg Psychiatry, 73:678–685.
7.
SramkaM, RattajM, MolinaH, VojtassakJ, BelanV, RuzickyE. 1992. Stereotactic technique and pathophysiological mechanisms of neurotransplantation in Huntington's chorea. Stereotact Funct Neurosurg, 58:79–83.
8.
BjorklundA, LindvallO. 2000. Cell replacement therapies for central nervous system disorders. Nat Neurosci, 3:537–544.
9.
HodgesH, PollockK, StroemerP, PatelS, StevanatoL, ReuterI, SindenJ. 2007. Making stem cell lines suitable for transplantation. Cell Transplant, 16:101–115.
10.
RobertsTJ, PriceJ, WilliamsSC, ModoM. 2006. Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease. Neuroscience, 139:1187–1199.
11.
RobertsTJ, PriceJ, WilliamsSC, ModoM. 2007. Pharmacological MRI of stem cell transplants in the 3-nitropropionic acid-damaged striatum. Neuroscience, 144:100–109.
12.
ArmstrongRJ, WattsC, SvendsenCN, DunnettSB, RosserAE. 2000. Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease. Cell Transplant, 9:55–64.
13.
KellyCM, DunnettSB, RosserAE. 2009. Medium spiny neurons for transplantation in Huntington's disease. Biochem Soc Trans, 37:323–328.
14.
HodgesH, WattsH, ReuterI. 2003. Stem cells: prospects for functional repair of brain damage. Transplant Proc, 35:1250–1255.
15.
GrecoSJ, RameshwarP. 2010. Recent advances and novel approaches in deriving neurons from stem cells. Mol Biosyst, 6:324–328.
LaengP, PittsRL, LemireAL, DrabikCE, WeinerA, TangH, ThyagarajanR, MallonBS, AltarCA. 2004. The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J Neurochem, 91:238–251.
18.
MacholdR, HayashiS, RutlinM, MuzumdarMD, NeryS, CorbinJG, Gritli-LindeA, DellovadeT, PorterJA, RubinLL, DudekH, McMahonAP, FishellG. 2003. Sonic hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches. Neuron, 39:937–950.
19.
SinhaS, ChenJK. 2006. Purmorphamine activates the Hedgehog pathway by targeting Smoothened. Nat Chem Biol, 2:29–30.
20.
WuX, WalkerJ, ZhangJ, DingS, SchultzPG. 2004. Purmorphamine induces osteogenesis by activation of the hedgehog signaling pathway. Chem Biol, 11:1229–1238.
21.
LiXJ, HuBY, JonesSA, ZhangYS, LavauteT, DuZW, ZhangSC. 2008. Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules. Stem Cells, 26:886–893.
22.
EricsonJ, MuhrJ, JessellTM, EdlundT. 1995. Sonic hedgehog: a common signal for ventral patterning along the rostrocaudal axis of the neural tube. Int J Dev Biol, 39:809–16.
23.
KohtzJD, BakerDP, CorteG, FishellG. 1998. Regionalization within the mammalian telencephalon is mediated by changes in responsiveness to Sonic Hedgehog. Development, 125:5079–5089.
24.
NakaoN, BrundinP, FunaK, LindvallO, OdinP. 1995. Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro. Brain Res Dev Brain Res, 90:92–101.
25.
JohanssonS, PriceJ, ModoM. 2008. Effect of inflammatory cytokines on major histocompatibility complex expression and differentiation of human neural stem/progenitor cells. Stem Cells, 26:2444–2454.
26.
PollockK, StroemerP, PatelS, StevanatoL, HopeA, MiljanE, DongZ, HodgesH, PriceJ, SindenJD. 2006. A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp Neurol, 199:143–155.
27.
AubryL, BugiA, LefortN, RousseauF, PeschanskiM, PerrierAL. 2008. Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc Natl Acad Sci U S A, 105:16707–16712.
28.
ToressonH, Mata de UrquizaA, FagerstromC, PerlmannT, CampbellK. 1999. Retinoids are produced by glia in the lateral ganglionic eminence and regulate striatal neuron differentiation. Development, 126:1317–1326.
29.
KallurT, DarsaliaV, LindvallO, KokaiaZ. 2006. Human fetal cortical and striatal neural stem cells generate region-specific neurons in vitro and differentiate extensively to neurons after intrastriatal transplantation in neonatal rats. J Neurosci Res, 84:1630–1644.
30.
NakaoN, OdinP, LindvallO, BrundinP. 1996. Differential trophic effects of basic fibroblast growth factor, insulin-like growth factor-1, and neurotrophin-3 on striatal neurons in culture. Exp Neurol, 138:144–157.
31.
GageFH, CoatesPW, PalmerTD, KuhnHG, FisherLJ, SuhonenJO, PetersonDA, SuhrST, RayJ. 1995. Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci U S A, 92:11879–11883.
32.
BibleE, ChauDY, AlexanderMR, PriceJ, ShakesheffKM, ModoM. 2009. Attachment of stem cells to scaffold particles for intra-cerebral transplantation. Nat Protoc, 4:1440–1453.
33.
FuccilloM, JoynerAL, FishellG. 2006. Morphogen to mitogen: the multiple roles of hedgehog signalling in vertebrate neural development. Nat Rev Neurosci, 7:772–783.
Gustafson EhrlichEM, TrivediPet al. 1992. In situ hybridization analysis of the development of DARPP-32 and ARPP-21 in rat striatum. Neuroscience, 51:65–75.
36.
OuimetCC, Langley-GullionKC, GreengardP. 1998. Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen. Brain Res, 808:8–12.
37.
GerfenCR. 1992. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci, 15:285–320.
38.
MarinO, AndersonSA, RubensteinJL. 2000. Origin and molecular specification of striatal interneurons. J Neurosci, 20:6063–6076.
39.
ParmarM, SjobergA, BjorklundA, KokaiaZ. 2003. Phenotypic and molecular identity of cells in the adult subventricular zone. in vivo and after expansion in vitro. Mol Cell Neurosci, 24:741–752.
40.
SousaVH, FishellG. 2010. Sonic hedgehog functions through dynamic changes in temporal competence in the developing forebrain. Curr Opin Genet Dev, 20:391–399.
41.
JainM, ArmstrongRJ, BarkerRA, RosserAE. 2001. Cellular and molecular aspects of striatal development. Brain Res Bull, 55:533–40.
42.
DanjoT, EirakuM, MugurumaK, WatanabeK, KawadaM, YanagawaY, RubensteinJL, SasaiY. 2011. Subregional specification of embryonic stem cell-derived ventral telencephalic tissues by timed and combinatory treatment with extrinsic signals. J Neurosci, 31:1919–1933.
43.
MagrassiL, EhrlichME, ButtiG, PezzottaS, GovoniS, CattaneoE. 1998. Basal ganglia precursors found in aggregates following embryonic transplantation adopt a striatal phenotype in heterotopic locations. Development, 125:2847–2855.
44.
WattsC, McNamaraIR, DunnettSB. 2000. Volume and differentiation of striatal grafts in rats: relationship to the number of cells implanted. Cell Transplant, 9:65–72.
45.
AanstadP, SantosN, CorbitKC, ScherzPJ, Trinh leA, SalvenmoserW, HuiskenJ, ReiterJF, StainierDY. 2009. The extracellular domain of Smoothened regulates ciliary localization and is required for high-level Hh signaling. Curr Biol, 19:1034–1039.
46.
StantonBZ, PengLF. 2010. Small-molecule modulators of the Sonic Hedgehog signaling pathway. Mol Biosyst, 6:44–54.
47.
RioboNA, SaucyB, DilizioC, ManningDR. 2006. Activation of heterotrimeric G proteins by Smoothened. Proc Natl Acad Sci U S A, 103:12607–12612.
48.
DessaudE, YangLL, HillK, CoxB, UlloaF, RibeiroA, MynettA, NovitchBG, BriscoeJ. 2007. Interpretation of the sonic hedgehog morphogen gradient by a temporal adaptation mechanism. Nature, 450:717–720.
49.
IvkovicS, EhrlichME. 1999. Expression of the striatal DARPP-32/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro. J Neurosci, 19:5409–5419.
50.
SkoghC, ParmarM, CampbellK. 2003. The differentiation potential of precursor cells from the mouse lateral ganglionic eminence is restricted by in vitro expansion. Neuroscience, 120:379–385.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
